|

Recombinant Interferon Alpha 2b-like Protein Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Novaferon, Recombinant IFN Alfa-2b-like Protein

Pipeline

Phase 1/2: 1

Top Sponsors

  • M.D. Anderson Cancer Center1

Indications

  • Liver Disease1
  • Unresectable Fibrolamellar Carcinoma1
  • Stage IIIB Hepatocellular Carcinoma AJCC v81
  • Stage IIIA Hepatocellular Carcinoma AJCC v81
  • Stage IVB Hepatocellular Carcinoma AJCC v81

Houston, Texas1 trial

Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer

M D Anderson Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.